Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

I. Morilla · SciRah

Researcher profile · Semantic Scholar

I. Morilla

Share profile

I. Morilla — researcher profile on SciRah

h-index: 16
Works: 60
Citations: 1,001

Most-cited papers

Functional systemic CD4 immunity is required for clinical responses to PD‐L1/PD‐1 blockade therapy
M. Zuazo, H. Arasanz, G. Fernández‐Hinojal, M. J. García-Granda +11 more
2019EMBO Molecular Medicine165 citations Open access
Semantic Scholar
Systematic Review and Meta-Analysis of Randomized, Controlled Trials on Preoperative Physical Exercise Interventions in Patients with Non-Small-Cell Lung Cancer
I. D. Rosero, R. Ramírez-Vélez, A. Lucía, N. Martínez-Velilla +4 more
2019Cancers125 citations Open access
Semantic Scholar
A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study
B. Martín-Castillo, S. Pernas, J. Dorca, I. Álvarez +24 more
2018OncoTarget74 citations Open access
Semantic Scholar
Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population
J. Gómez‐Miragaya, M. Palafox, L. Paré, G. Yoldi +18 more
2017Stem Cell Reports73 citations Open access
Semantic Scholar
Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics
H. Arasanz, M. Zuazo, A. Bocanegra, Maria Gato +12 more
2020Cancers70 citations Open access
Semantic Scholar
PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer
A. Bocanegra, G. Fernández‐Hinojal, Miren Zuazo-Ibarra, H. Arasanz +12 more
2019International Journal of Molecular Sciences60 citations Open access
Semantic Scholar
Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer
H. Arasanz, A. Bocanegra, I. Morilla, J. Fernández-Irigoyen +16 more
2022medRxiv44 citations Open access
Semantic Scholar
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
F. Mateo, E. Arenas, H. Aguilar, J. Serra-Musach +89 more
2016Oncogene38 citations Open access
Semantic Scholar
Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients
E. Cuyás, S. Fernández-Arroyo, M. Buxó, S. Pernas +21 more
2019Aging32 citations Open access
Semantic Scholar
Hyperprogressive Disease: Main Features and Key Controversies
H. Arasanz, M. Zuazo, A. Bocanegra, L. Chocarro +14 more
2021International Journal of Molecular Sciences26 citations Open access
Semantic Scholar
Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells
M. Abreu, P. Cabezas-Sáinz, Thais Pereira-Veiga, C. Falo +17 more
2020Journal of Clinical Medicine24 citations Open access
Semantic Scholar
The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin
E. Cuyás, M. Buxó, Maria José Ferri Iglesias, S. Verdura +22 more
2019Frontiers in Oncology24 citations Open access
Semantic Scholar
Effects of a Multicomponent Exercise Program in Older Adults with Non-Small-Cell Lung Cancer during Adjuvant/Palliative Treatment: An Intervention Study
I. D. Rosero, R. Ramírez-Vélez, N. Martínez-Velilla, B. Cedeño-Veloz +2 more
2020Journal of Clinical Medicine22 citations Open access
Semantic Scholar
CAR-T Cells for the Treatment of Lung Cancer
L. Chocarro, H. Arasanz, L. Fernández-Rubio, E. Blanco +12 more
2022Life20 citations Open access
Semantic Scholar
Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance
Gorka Ruiz de Garibay, F. Mateo, A. Stradella, R. Valdés-Mas +18 more
2018Disease Models & Mechanisms19 citations Open access
Semantic Scholar
PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution
S. Pernas, A. Petit, F. Climent, L. Paré +12 more
2019Frontiers in Oncology17 citations Open access
Semantic Scholar
Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer
E. López-Bonet, M. Buxó, E. Cuyás, S. Pernas +23 more
2019Journal of Clinical Medicine16 citations Open access
Semantic Scholar
Geriatric oncology in Spain: survey results and analysis of the current situation
R. Gironés, I. Morilla, Carmen Guillén-Ponce, María Dolores Torregrosa +16 more
2017Clinical and Translational Oncology15 citations Open access
Semantic Scholar
Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness
Gorka Ruiz de Garibay, C. Herranz, A. Llorente, J. Boni +35 more
2015PLoS ONE15 citations Open access
Semantic Scholar
Identification of a Dexamethasone Mediated Radioprotection Mechanism Reveals New Therapeutic Vulnerabilities in Glioblastoma
P. Aldaz, Jaione Auzmendi-Iriarte, Maika Durántez, Irene Lasheras-Otero +17 more
2021Cancers14 citations Open access
Semantic Scholar
Secondary orbital metastases from cutaneous melanoma.
C. Conill, I. Morilla, J. Malvehy, I. Toscas +2 more
2004Melanoma research14 citations
Semantic Scholar
Plasma fractalkine contributes to systemic myeloid diversity and PD‐L1/PD‐1 blockade in lung cancer
A. Bocanegra, G. Fernández‐Hinojal, D. Ajona, E. Blanco +23 more
2023EMBO Reports13 citations Open access
Semantic Scholar
Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics
M. Provencio, M. Cobo, D. Rodríguez-Abreu, V. Calvo +27 more
2022BMC Cancer13 citations Open access
Semantic Scholar
Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center
M. B. Sirvén, A. Fernández-Ortega, A. Stradella, I. Morilla +8 more
2019BMC Pharmacology and Toxicology13 citations Open access
Semantic Scholar
Metaplastic Carcinoma of the Breast with Chondroid Differentiation (Matrix-Producing Carcinoma): Study of the Diagnostic Cost-Effectiveness of Fine-Needle Aspiration Biopsy and Needle Core Biopsy
M. T. Soler Monsó, I. Catalá, M. Terricabras, A. Petit +4 more
2013Acta Cytologica8 citations
Semantic Scholar
Muscle metastasis of low-grade endometrial carcinoma seven years after diagnosis: a case report.
A. Oaknin, M. P. Barretina, I. Morilla
2010European Journal of Gynaecological Oncology8 citations
Semantic Scholar
Multicomponent Exercise Program in Older Adults with Lung Cancer During Adjuvant/Palliative Treatment: A Secondary Analysis of an Intervention Study
N. Martínez-Velilla, M. L. D. de Asteasu, R. Ramírez-Vélez, I. D. Rosero +6 more
2021The Journal of frailty & aging7 citations Open access
Semantic Scholar
Denosumab as an immune modulator in HER2-negative early breast cancer: results of the window-of-opportunity D-BIOMARK clinical trial
A. Vethencourt, E. M. Trinidad, E. Dorca, Anna Petit +17 more
2025Breast Cancer Research5 citations Open access
Semantic Scholar
Incidence of second primary cancers in lung cancer survivors by oncological treatment: a nationwide prospective cohort study in Spain
M. Provencio, M. Cobo, D. Rodríguez-Abreu, E. Carcereny +61 more
2025The Lancet Regional Health - Europe5 citations Open access
Semantic Scholar
Effects of an individualised exercise program in hospitalised older adults with cancer: A randomised clinical trial
M. Ferrara, F. Zambom-Ferraresi, A. Castillo, M. Delgado +6 more
2024The Journal of Nutrition, Health & Aging5 citations Open access
Semantic Scholar
Circulating low-density neutrophils as biomarkers of resistance to first-line anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer
N. Castro, I. Labiano, M. Martínez-Aguillo, A. Huerta +16 more
2026Translational Oncology3 citations Open access
Semantic Scholar
Eribulin Mesylate in Breast Cancer
H. Verdaguer, I. Morilla, A. Urruticoechea
2013Women's Health3 citations Open access
Semantic Scholar
Larotrectinib in patients with tropomyosin receptor kinase fusion solid tumors in Spain (SPAINTRK).
J. Hernando, C. López, A. García-Álvarez, Santiago Aguín Losada +12 more
2026European Journal of Cancer2 citations
Semantic Scholar
Abstract P2-09-11: PAM50 intrinsic subtyping as a predictor of pathological complete response to neoadjuvant trastuzumab-based chemotherapy in early HER2-positive breast cancer
S. Pernas, A. Petit, F. Climent, L. Paré +10 more
20182 citations
Semantic Scholar
Functional systemic CD4 immunity is a differential factor for clinical responses to PD-L1/PD-1 blockade therapy in lung cancer
M. Zuazo, H. Arasanz, G. Fernández‐Hinojal, M. J. García-Granda +11 more
2018bioRxiv2 citations Open access
Semantic Scholar
Abstract P1-10-01: Safety and efficacy of neoadjuvant metformin with trastuzumab and chemotherapy in women with HER2-positive early breast cancer: A randomized, open-label, multicenter, phase 2 trial
S. Pernas, J. Dorca, I. Álvarez-López, S. Martínez +21 more
20182 citations
Semantic Scholar
Crizotinib in advanced ALK-positive non-small cell lung cancer: Results of a retrospective cohort in Complejo Hospitalario de Navarra, Spain.
B. Hernández, Maite Martínez, L. Teijeira, David Guerrero +13 more
20142 citations
Semantic Scholar
Correction: Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness
Gorka Ruiz de Garibay, C. Herranz, A. Llorente, J. Boni +35 more
2018PLoS ONE1 citations Open access
Semantic Scholar
Colorectal surgery in the elderly: Does the extreme age determine the odds ratio of complications?
G. Soler, M. Martinez-Vilalta, J. Vallet, A. Sueiras +15 more
20181 citations
Semantic Scholar
Efficacy of taxanes followed by anthracyclines as neoadjuvant therapy in HER2-negative breast cancer (BC): Analysis of everyday clinical practice.
E. Rodríguez, C. F. Zamora, M. Gil, P. Anna +6 more
20171 citations
Semantic Scholar
Clinical outcomes of KRAS G12C versus non-G12C mutant NSCLC treated with immunotherapy: a multicentre real-world study.
L. Masfarré, A. Parreira, Natalia Castro, Claudia Miquel +15 more
2026Lung Cancer0 citations Open access
Semantic Scholar
Management of glioblastoma in the elderly.
I. Morilla, Edinson Caviedes, Regina Gironés Sarrió, Borja López de San Vicente Hernández +4 more
2026Clinical and Translational Oncology0 citations Open access
Semantic Scholar
Long-term survival and biomarkers of immunotherapy in small cell lung cancer: a systematic review
S. Laguna, A. Sádaba, I. Morilla, L. Teijeira +16 more
2026Translational Lung Cancer Research0 citations Open access
Semantic Scholar
P25.03.B RWD OF IDH MUTANT GLIOMAS IN SPAIN, A RETSINE - GEINO STUDY
M. Mazariegos, R. Gironés, S. del Barco, A. García +29 more
2024Neuro-Oncology0 citations Open access
Semantic Scholar
Prolonged disease control with local treatments in oligo-acquired resistance to immune-checkpoint inhibitors
H. Arasanz, I. Morilla, M. Martínez-Aguillo, L. Teijeira +2 more
2023Translational Lung Cancer Research0 citations Open access
Semantic Scholar
Potent clinical prognostic and systemic adjuvant therapeutic value of plasma fractalkine in PD-L1/PD-1 blockade immunotherapy for lung cancer
A. Bocanegra, G. Fernandez, D. Ajona, H. Arasanz +19 more
2022medRxiv0 citations Open access
Semantic Scholar
Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics
M. Provencio, M. Cobo, D. Rodríguez-Abreu, V. Calvo +27 more
2022BMC Cancer0 citations Open access
Semantic Scholar
8P Immune cell subsets in peripheral blood are associated with primary resistance to immunotherapy as frontline treatment in NSCLC
H. Arasanz, M. Zuazo, L. Chocarro, A. I. Bocanegra Gondan +10 more
20200 citations Open access
Semantic Scholar
Corrigendum: PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution
S. Pernas, A. Petit, F. Climent, L. Paré +12 more
2019Frontiers in Oncology0 citations Open access
Semantic Scholar
Real-world data of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center
M. B. Sirvén, A. Fernández-Ortega, A. Stradella, I. Morilla +8 more
20190 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Pernas×15
Invite
S. Pernas — researcher profile on SciRah
H. Arasanz×13
Invite
H. Arasanz — researcher profile on SciRah
L. Teijeira×12
Invite
L. Teijeira — researcher profile on SciRah
R. Vera×11
Invite
R. Vera — researcher profile on SciRah

×11

Invite

D. Escors — researcher profile on SciRah

A. Stradella×11

Invite

A. Stradella — researcher profile on SciRah

A. Bocanegra×9

Invite

A. Bocanegra — researcher profile on SciRah

Invite

G. Kochan — researcher profile on SciRah

M. Martínez-Aguillo×9

Invite

M. Martínez-Aguillo — researcher profile on SciRah

Invite

M. Zuazo — researcher profile on SciRah

Invite

C. Falo — researcher profile on SciRah

Invite

F. Climent — researcher profile on SciRah